Systematic in vitro analysis of therapy resistance in glioblastoma cell lines by integration of clonogenic survival data with multi-level molecular data

Despite intensive basic scientific, translational, and clinical efforts in the last decades, glioblastoma remains a devastating disease with a highly dismal prognosis. Apart from the implementation of temozolomide into the clinical routine, novel treatment approaches have largely failed, emphasizing...

Descripción completa

Detalles Bibliográficos
Autores principales: Schnöller, Leon Emanuel, Piehlmaier, Daniel, Weber, Peter, Brix, Nikko, Fleischmann, Daniel Felix, Nieto, Alexander Edward, Selmansberger, Martin, Heider, Theresa, Hess, Julia, Niyazi, Maximilian, Belka, Claus, Lauber, Kirsten, Unger, Kristian, Orth, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10007763/
https://www.ncbi.nlm.nih.gov/pubmed/36906590
http://dx.doi.org/10.1186/s13014-023-02241-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10007763/
https://www.ncbi.nlm.nih.gov/pubmed/36906590
http://dx.doi.org/10.1186/s13014-023-02241-4

Ejemplares similares